This site is intended for health professionals only

LIVE Session

July 5, 2022 - Time: 13:00 - 13:45



In order to view this virtual session, you must be logged in.

If you haven't registered for this event, please register here first.

What’s new in heart failure

New pharmacological therapies and the role of devices

  • Understanding the 4 pillars of pharmacological therapy for HFrEF
  • The role of device therapy in HF to optimise outcomes
  • Innovative technology in Primary care to facilitate HF surveillance
After this session, the next one will start at 14:00

Genomic testing for the prevention of CVD and other common diseases


Dr Yassir Javaid

MA (Cantab) FRCP FRCGP PGDip Cardiology. Cardiovascular and diabetes lead Northamptonshire CCG, primary care CVD lead East Midlands Clinical Network (2013-2020)

Dr Javaid qualified from Cambridge University and completed his VTS training in Northampton. He has a specialist interest in cardiology and echocardiography and was a clinical lead in the Northamptonshire Community Cardiology service, which had a focus on patients with heart failure and valve disease. He was named Pulse “GP of the Year” in 2015 for his work in reducing stroke emergency admissions in the East Midlands. He is also a council member of the British Heart Valve Society, accredited member of the British Society of Echocardiography and on the editorial board for the British Journal of Cardiology.

You might also be interested in: